Share this post on:

Product Name :
GSK-983

Search keywords :
GSK983

drugId :
null

Target Vo:
p300-CBP transcription factors

Target Vo Short Name :
p300/CBP

Moa_Name:
p300-CBP transcription factors inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Glaxosmithkline Plc

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Patritumab Data Sheet
Phospho-MLKL (Ser358) Antibody (YA1623) custom synthesis
Cy3-conjugated AffiniPure Goat Anti-Rabbit IgG H&L: Cy3-conjugated AffiniPure Goat Anti-Rabbit IgG H&Lis an -conjugated, goat-derived anti-rabbit IgG antibody. Cy3-conjugated AffiniPure Goat Anti-Rabbit IgG H&L conjugates the light and heavy chains of rabbit IgG antibodies for use in ICC/IF, IHC-F, IHC-P, FC, ELISA experiments in the rabbit context.

Share this post on:

Author: Interleukin Related